ROYAL BANK OF CANADA - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$687,000
+66.3%
43,341
+98.0%
0.00%
Q2 2023$413,000
+70.7%
21,891
-65.2%
0.00%
Q1 2023$242,000
-56.8%
62,932
-44.3%
0.00%
Q4 2022$560,000
-0.5%
113,008
-4.0%
0.00%
Q3 2022$563,000
+23.2%
117,730
+15.9%
0.00%
Q2 2022$457,000
-22.9%
101,605
-18.4%
0.00%
Q1 2022$593,000
-48.8%
124,570
-20.3%
0.00%
Q4 2021$1,159,000
+46.0%
156,201
+11.7%
0.00%
Q3 2021$794,000
-9.2%
139,787
+5.3%
0.00%
Q2 2021$874,000
-39.8%
132,749
-25.9%
0.00%
Q1 2021$1,452,000
+25.6%
179,161
+0.0%
0.00%
Q4 2020$1,156,000
+40.3%
179,104
-21.8%
0.00%
Q3 2020$824,000
-9.5%
229,001
+15.5%
0.00%
Q2 2020$911,000
+89.8%
198,193
+40.7%
0.00%
Q1 2020$480,000
-33.1%
140,816
+0.2%
0.00%
Q4 2019$717,000
+103.1%
140,484
-3.7%
0.00%
Q3 2019$353,000
+14.6%
145,887
+2.9%
0.00%
Q2 2019$308,000
-9.1%
141,756
+13.2%
0.00%
Q1 2019$339,000
-42.2%
125,232
+2.3%
0.00%
Q4 2018$587,000
-52.4%
122,447
-5.9%
0.00%
-100.0%
Q3 2018$1,233,000
+8.8%
130,143
+11.8%
0.00%0.0%
Q2 2018$1,133,000
-17.4%
116,384
-10.7%
0.00%0.0%
Q1 2018$1,372,000
-4.1%
130,388
-41.6%
0.00%0.0%
Q4 2017$1,431,000
+12.8%
223,138
+34.5%
0.00%0.0%
Q3 2017$1,269,000
+15.6%
165,938
+7.5%
0.00%0.0%
Q2 2017$1,098,000
+1514.7%
154,432
+789.0%
0.00%
Q1 2017$68,000
+74.4%
17,371
-11.5%
0.00%
Q4 2016$39,000
-13.3%
19,624
+17.0%
0.00%
Q3 2016$45,000
-27.4%
16,776
-15.1%
0.00%
Q2 2016$62,000
-62.9%
19,760
+0.5%
0.00%
Q1 2016$167,000
-55.6%
19,658
-29.1%
0.00%
Q4 2015$376,000
+46.9%
27,737
+3.8%
0.00%
Q3 2015$256,000
-24.5%
26,716
+13.3%
0.00%
Q2 2015$339,000
+62.2%
23,585
+1.1%
0.00%
Q1 2015$209,000
+20.1%
23,336
-18.0%
0.00%
Q4 2014$174,000
-8.4%
28,470
+58.3%
0.00%
Q3 2014$190,000
-53.4%
17,989
-47.8%
0.00%
Q2 2014$408,000
-0.2%
34,444
+25.7%
0.00%
Q1 2014$409,000
+23.6%
27,404
+21.5%
0.00%
Q4 2013$331,000
-32.0%
22,549
-21.3%
0.00%
Q3 2013$487,000
-8.5%
28,658
-10.8%
0.00%
Q2 2013$532,00032,1410.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders